Pfizer challenges NICE drug approval decisions

Pfizer and its Japanese partner Eisai Co. are preparing for a court fight June 25 challenging the U.K.'s National Institute for Clinical Health and Excellence. The companies oppose NICE's process for approving or rejecting drugs for government subsidies. NICE argues it is only seeking good value for the money spent on drugs.

View Full Article in:

Independent (London) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC